Enjoliqué Aytch Lett Shareholder at Greenberg Sad. Courtesy photo
Greenberg Traurig has added shareholder Enjoliqué Aytch Lett to its Miami-based product liability practice. Lett, who most recently served as senior attorney for Akerman’s medical device group, will represent pharmaceutical companies and medical device manufacturers in litigation at high stakes in Greenberg, the firm said this week.
In an interview, Lett said she is bringing two former Akerman customers to Greenberg, including agents for Chinese drywall manufacturer Taishan Gypsum Co. Ltd, which is facing litigation over concerns over toxic drywall work.
Lett has represented several high profile clients in complex commercial disputes, including Under Armor, and served as the senior attorney in the country’s first hernia mesh dispute.
Lett said she looks forward to continuing her work in medical device liability and expanding into pharmaceutical company liability defense at Greenberg. “Most of the country needs a medical device or drug,” she said. “Due to the enormous expansion of the market base, legal disputes could arise.”
The pandemic has not hampered Lat’s ability to represent clients in court, she said. “Fortunately, there was a very robust video conferencing platform,” said Lett. “We have held hearings and made statements on numerous video conferencing platforms. I didn’t feel any interruption in the practice. “
Lett worked as an associate in the Atlanta law firm’s Am Law 50 office between 2009 and 2012 and said she was in touch with Lori G. Cohen, who chairs the litigation practice for pharmaceutical, medical device and health care at Greenberg. Lett credits Cohen and a practice shareholder Sabrina R. Gallo with the expansion of the group, which last year added shareholder Rebecca A. Ocariz and associate Akiesha Gilcrist Sainvil.
“Greenberg’s product liability practice has grown tremendously as has its Miami office practice,” said Lett. “I’ve been fortunate to keep in touch with Lori and the Greenberg product group and watch it expand to other products, and I’ve also done my own expansion on mass killing work.”